Sudharsan Parthasarathy | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Sudharsan Parthasarathy | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Mr Sudharsan Parthasarathy, Nagaland Central University, India

Sudharsan Parthasarathy is a passionate researcher currently pursuing his Ph.D. in Forestry at Nagaland University, India. His academic interests bridge the domains of Neurodegenerative Disorders, Cognitive Psychology, Medicinal Plants, and Natural Products. He has authored 18 peer-reviewed journal articles, 14 book chapters, 6 multilingual books, and holds 4 patents (3 national and 1 international). With over 96 citations and an H-index of 6, he has earned recognition in scientific communities. Sudharsan has actively presented his work in various national and international conferences and has received multiple best presentation awards. He serves as Section Editor for Plant Science Today and is a reviewer for several prestigious journals including Phytomedicine and BMC Pharmacology & Toxicology. He is a life member of global scientific organizations such as the International Society of Neurochemistry and Alzheimer Disease International. His contributions reflect his dedication to integrating traditional medicinal knowledge with cutting-edge biomedical research.

Publication Profile

orcid

Education

Sudharsan Parthasarathy is presently enrolled as a Ph.D. scholar in the Department of Forestry at Nagaland University, Lumami, Zunheboto, Nagaland, India. He is undertaking interdisciplinary research focusing on neuroscience, plant-based pharmacology, and natural product applications for neurological and metabolic disorders. His academic foundation includes robust training in biology, botany, and pharmacology, fostering a unique synthesis of cognitive science and natural therapeutics. Over the course of his doctoral journey, he has applied advanced methodologies such as in-silico modeling, molecular dynamics, gene expression analysis, and bioinformatics, combining them with empirical botanical studies. His academic excellence is further reflected through his selection for the UGC NON-NET Fellowship (2022–2025). With his diverse educational background and hands-on research experience, Sudharsan has positioned himself at the intersection of modern science and traditional knowledge, contributing toward innovative solutions for health and environmental challenges through integrative and sustainable research practices.

Experience

Sudharsan Parthasarathy brings multifaceted academic and research experience as a scholar, author, reviewer, and editor. While pursuing his Ph.D. at Nagaland University, he has published 18 peer-reviewed papers and 14 book chapters. He has co-authored six books in multiple languages, broadening accessibility in scientific discourse. He currently serves as Section Editor for Plant Science Today (Horizon e-Publishing) and has peer-reviewed articles for journals like Phytomedicine, International Journal of Biological Macromolecules, Applied Biochemistry and Biotechnology, and Desalination and Water Treatment. He has participated in 6 national and international conferences, contributing as a presenter and winning top awards. Sudharsan has developed significant expertise in medicinal plant research, nanoparticle-based drug delivery, and molecular biology tools. His exposure to interdisciplinary projects reflects his ability to navigate both laboratory and field-based research environments. His practical understanding of virtual screening, gene interaction modeling, and biotechnological applications has enabled him to take part in cross-functional collaborative research.

Awards and Honors

Sudharsan Parthasarathy has received several accolades for his academic and research excellence. He was awarded the Best Oral Presentation Award at the 4th International Conference on Biotechnological Approach for Human Health Problems (ICBAHHP-2025) held at Jamal Mohamed College, Trichy. In 2024, he earned another Best Oral Presentation Award at the ICBAGEP-2024. In 2023, he was honored as the Young Scientist Best Oral Presenter at the 4th International Conference on Environmental Agricultural Chemical and Biological Sciences. He received the Best Scholar Award at the Global Iconic Awards 2022 hosted by ESN Publication at Taj Vivanta, Goa. He is also a recipient of the UGC NON-NET Fellowship (2022–2025). These honors reflect his consistent performance in academic communication and his impactful contributions to biotechnological and environmental sciences. Additionally, his editorial and peer-review roles signify the recognition of his expertise by reputed international journals and professional bodies.

Research Focus

Sudharsan Parthasarathy’s research focuses on Neurodegenerative Disorders, Cognitive Psychology, Medicinal Plants, and Natural Products. His work integrates traditional medicinal knowledge with modern biotechnological approaches. He explores natural bioactives such as piperine, resveratrol, and plant-derived peptides for treating disorders like Alzheimer’s, polycystic ovary syndrome, and aging-related diseases. His studies span in-silico modeling, molecular docking, nanoparticle drug delivery, and gene interaction studies, with a keen interest in hTERT gene interventions and antioxidant pathways. He also investigates microbial and aquatic bioresources for novel antimicrobial agents. His interdisciplinary methods combine phytochemistry, biochemistry, and computational biology, enabling effective therapeutic exploration and safety analysis. With a passion for translational science, he aims to bridge the gap between lab-based findings and clinical applications. His long-term vision includes developing sustainable, plant-based treatments for neurological and metabolic conditions and contributing to global health through scientific innovation and academic collaboration.

Publication Top Notes

  1. 🧪 Development of Novel Piperine‐Loaded Mesoporous Silica Nanoparticles: Enhanced Drug Delivery and In Vivo Safety Analysis – Chemistry & Biodiversity (2025)

  2. 🧬 Evaluation of Potential EGFR Inhibitors for Non-small Cell Lung Cancer: A Structure-based Screening Study – JPRI (2024)

  3. 🧠 In Vivo Molecular Functional Aging and hTERT Gene as Antiaging Intervention in Danio rerio – UP Journal of Zoology (2024)

  4. 🧫 Piperine’s Potential in Treating Polycystic Ovarian Syndrome Explored Through In-silico Docking – Scientific Reports (2024)

  5. 🌿 Exploring Piperine for PCOS: In-silico Docking Insights – Preprint (2024)

  6. 🍇 Antiaging Compounds from Medicinal Plants & Resveratrol Binding with hTERT Gene – Biochemical & Cellular Archives (2024)

  7. 🐟 Antimicrobial Peptides from Clarias batrachus Catfish Epidermis – IJPRT (2024)

  8. 🍄 Elevating Health with Cordyceps Militaris: The Ultimate Food Supplement – IJoALS (2023)

  9. 🌾 Biofortification to Overcome Malnutrition – An Overview – IJoALS (2023)

  10. 🧪 Fabrication and Characterization of Silver Nanoparticles Using Illicium Verum Seed Extract – IJCRT (2023)

  11. 🌱 (Title truncated; please provide complete title for entries 11–18 for full listing)

Deepti Pandita | Pharmacology | Best Researcher Award

Prof. Deepti Pandita | Pharmacology | Best Researcher Award

Prof. Deepti Pandita, Delhi Pharmaceutical Sciences & Research University, New Delhi, India

Prof. Deepti Pandita is a distinguished academic and professional serving as a Professor at the Delhi Pharmaceutical Sciences & Research University (DPSRU), New Delhi, India, since May 2020. She holds key leadership roles as the PhD Coordinator and the Training & Placement Head at DPSRU, contributing significantly to academic administration and student career development.

Education

PhD in Pharmaceutics (2008)

Institution: Jamia Hamdard, Hamdard University, New Delhi

Thesis Topic: “Development and evaluation of submicron lipid nanoparticles for the oral delivery of paclitaxel”

Fellowship: ICMR – Senior Research Fellow (2005–2008)

Reference: SR/FT/LS145/2011

Master of Pharmacy in Pharmaceutics (2002)

Institution: Manipal College of Pharmaceutical Sciences, MAHE, Karnataka

Aggregate: 78.86%

Bachelor of Pharmacy (1997)

Institution: Mysore University, Karnataka

Aggregate: 74.59%

MBA in Marketing (2013)

Institution: M. D. University, Rohtak (Distance Mode)

Aggregate: 66.11%

Higher Secondary Education (XII Class) (1995)

Board: CBSE, Delhi

Aggregate: 63%

Secondary Education (X Class) (1993)

Board: CBSE, Delhi

Aggregate: 78%

Registered Pharmacist

Registration Number: 14991

Date: 11.10.2002

Issuing Authority: Delhi Pharmacy Council

Professional Profiles

Google Scholar

ORCID Profile

Professional Experience

Professor
Delhi Pharmaceutical Sciences & Research University (DPSRU), Govt. of NCT of Delhi, New Delhi, India
May 27, 2020 – Present

Associate Professor
Amity University Uttar Pradesh, Noida
June 4, 2018 – April 4, 2020

Professor & Head
JCDM College of Pharmacy, Sirsa
October 12, 2012 – June 1, 2018

Associate Professor & Head
JCDM College of Pharmacy, Sirsa
August 18, 2010 – October 11, 2012

Postdoctoral Fellow
CQM, University of Madeira, Portugal
June 1, 2008 – July 31, 2010

Assistant Professor
SBMN Institute of Pharmaceutical Sciences & Research, M.D. University, Rohtak
September 24, 2002 – July 31, 2003

Research Interests

Nanomedicine & Nanotheranostics

Bioconjugates

Stem Cell Research for Tissue Engineering

Drug Discovery & Repurposing

3D Printing for Personalized & Precision Medicine

Targeted Phytochemical Delivery

Top Notable Publications

Therapeutic Potential of Isoliquiritigenin in Breast Cancer

Journal: Naunyn-Schmiedeberg’s Archives of Pharmacology (2024)

DOI: 10.1007/s00210-024-03282-6

Contributors: Divya Sharma, Mahaveer Dhobi, Viney Lather, Deepti Pandita

This research explores the therapeutic effects of isoliquiritigenin on breast cancer treatment.

 

CDC20 Inhibitors in Breast Cancer

Journal: 3 Biotech (2023)

DOI: 10.1007/s13205-023-03554-7

Contributors: Amiya Das, Hitesh Kumar Sharma, Viney Lather, Deepti Pandita, Pallavi Agarwal

Focuses on the identification and evaluation of CDC20 inhibitors as potential therapeutic agents for breast cancer.

 

Drug Repurposing for Triple-Negative Breast Cancer

Journal: Anti-Cancer Agents in Medicinal Chemistry (2022)

DOI: 10.2174/1871520621666211021143255

Contributors: Amiya Das, Pallavi Agarwal, Gaurav Kumar Jain, Geeta Aggarwal, Viney Lather, Deepti Pandita

Examines novel therapeutic options through drug repurposing for aggressive breast cancer types.

 

Protective Effects of Dalbergia sissoo

Journal: Turkish Journal of Pharmaceutical Sciences (2021)

DOI: 10.4274/tjps.galenos.2020.04379

Contributors: Raheja S., Girdhar A., Kamboj A., Lather V., Pandita D.

Studies the neuroprotective effects of Dalbergia sissoo against oxidative stress and memory impairment.

 

Phytoconstituents in COVID-19 Management

Journal: Chemico-Biological Interactions (2021)

DOI: 10.1016/j.cbi.2021.109449

Contributors: Das A., Pandita D., Jain G.K., Agarwal P., Grewal A.S., Khar R.K., Lather V.

Explores the potential of phytoconstituents in combating COVID-19.

 

Biomedical Applications of Extracellular Matrix Extraction Techniques

Journal: Regenerative Medicine (2021)

DOI: 10.2217/rme-2021-0021

Contributors: Kirthanashri S. Vasanthan, Varadharajan Srinivasan, Deepti Pandita

Discusses innovative extracellular matrix techniques for biomedical engineering.

 

Paclitaxel Hybrid Nanoparticles for Cancer Therapy

Journal: Materials Science and Engineering C (2020)

DOI: 10.1016/j.msec.2019.110576

Contributors: Godara S., Lather V., Kirthanashri S.V., Awasthi R., Pandita D.

Details advancements in lipid-PLGA nanoparticles for enhanced cancer treatment.

 

Cinnamic Acid Derivatives for Metabolic Syndrome

Journal: Current Drug Discovery Technologies (2020)

DOI: 10.2174/1570163816666190314124543

Contributors: Chauhan A., Grewal A.S., Pandita D., Lather V.

Investigates novel cinnamic acid derivatives as PPARδ agonists.

 

Methotrexate and Resveratrol Nanoemulsions

Journal: Assay and Drug Development Technologies (2020)

DOI: 10.1089/adt.2020.989

Contributors: Poonia N., Lather V., Kaur B., Kirthanashri S.V., Pandita D.

Optimizes nanoemulsions for rheumatoid arthritis treatment.

 

Resveratrol-Loaded Nanoparticles

Journal: Materials Science and Engineering C (2020)

DOI: 10.1016/j.msec.2020.111016

Contributors: Poonia N., Lather V., Narang J.K., Beg S., Pandita D.

Develops lipoprotein-mimetic nanoparticles for improved drug delivery systems.

Conclusion

Prof. Deepti Pandita is a highly deserving candidate for the “Research for Best Researcher Award,” with her strong foundation in impactful research, innovative methodologies, and multidisciplinary expertise. Her contributions to oncology, neuropharmacology, and drug delivery systems stand out as significant advancements in the field of pharmacology.